Altered gut microbiota is associated with the formation of occult hepatitis B virus infection

Bochao Liu,Hualong Yang,Qiao Liao,Min Wang,Jieting Huang,Ru Xu,Zhengang Shan,Huishan Zhong,Tingting Li,Chengyao Li,Yongshui Fu,Xia Rong
DOI: https://doi.org/10.1128/spectrum.00239-24
IF: 3.7
2024-05-25
Microbiology Spectrum
Abstract:ABSTRACT Hepatitis B virus (HBV), a common blood transmission pathogen worldwide, can lead to viral hepatitis, cirrhosis, liver cancer, and other liver diseases. In particular, occult hepatitis B virus infection (OBI) may be caused by an immune response leading to suppressed virus replication. Gut microbiota can change the immunity status of the human body and, therefore, affect the replication of HBV. Thus, to identify whether there are differences in gut microbiota between HBV carriers and OBI carriers, we collected fecal samples from 18 HBV carriers, 24 OBI blood donors, and also 20 healthy blood donors as negative control. After 16S sequencing, we found that the abundance of Faecalibacterium was significantly reduced in samples from OBI blood donors compared with those from healthy blood donors. Compared with samples from HBV carriers, the samples from OBI blood donors had a significantly increased abundance of Subdoligranulum , which might stimulate immune activation, thus inhibiting HBV replication and contributing to the formation of occult infection. Our findings revealed the potential role of gut microbiota in the formation of OBI and further provided a novel strategy for the treatment of HBV infection. IMPORTANCE Occult hepatitis B virus infection (OBI) is a special form of hepatitis B virus infection with hepatitis B surface antigen (HBsAg) positive and hepatitis B virus (HBV) DNA negative. Gut microbiota may contribute to the immune response leading to suppressed virus replication and, thus, participates in the development of OBI. The study on gut microbiota of OBI blood donors provides novel data considerably advancing our understanding of the immune mechanism for the determination of occult hepatitis B virus infection, which is helpful for improving the strategy of the treatment of HBV infection.
microbiology
What problem does this paper attempt to address?
### The Problem the Paper Attempts to Solve This paper aims to explore the role of gut microbiota in the formation of Occult Hepatitis B Virus Infection (OBI). Specifically, the researchers hope to identify differences in gut microbiota by analyzing fecal samples from different groups (HBV carriers, OBI blood donors, and healthy blood donors), to reveal whether these differences are related to the immune response of OBI, and to further explore the potential impact of these findings on HBV infection treatment strategies. ### Background and Importance Hepatitis B Virus (HBV) is a common blood-borne pathogen that can cause viral hepatitis, cirrhosis, liver cancer, and other liver diseases. Occult Hepatitis B Virus Infection (OBI) is a special form of HBV infection characterized by HBsAg-negative but HBV DNA-positive. OBI blood donors may transmit HBV to recipients through blood transfusion, leading to typical hepatitis B. Additionally, when OBI patients receive chemotherapy or other immunosuppressive treatments, HBV may reactivate. Therefore, understanding the immune mechanisms of OBI is crucial for improving HBV infection treatment strategies. ### Research Methods 1. **Sample Collection**: Researchers collected fecal samples from 18 HBV carriers, 24 OBI blood donors, and 20 healthy blood donors. 2. **16S Sequencing**: The composition of gut microbiota in fecal samples was analyzed using 16S rRNA gene sequencing technology. 3. **Immune Status Assessment**: The immune status of different groups was assessed by detecting cytokine secretion of peripheral blood mononuclear cells (PBMCs) under HBV core peptide stimulation through ELISA and ELISpot assays. ### Main Findings 1. **Differences in Microbiota Composition**: - In the fecal samples of OBI blood donors, the abundance of Subdoligranulum significantly increased, while the abundance of Faecalibacterium significantly decreased. - Compared to HBV carriers, OBI blood donors had a higher abundance of Subdoligranulum, which may stimulate immune activation, thereby inhibiting HBV replication and promoting the formation of occult infection. 2. **Differences in Immune Response**: - The secretion levels of IFN-γ and IL-17A in PBMCs of the OBI group under HBV core peptide stimulation were significantly higher than those in the healthy control group (HC) and HBV carriers, indicating a stronger immune response in the OBI group, which helps inhibit HBV replication. ### Conclusion This study reveals the potential role of gut microbiota in the formation of OBI, particularly the increase of Subdoligranulum, which may inhibit HBV replication by stimulating immune activation. These findings provide new strategies for the treatment of HBV infection, namely, enhancing the immune response by regulating gut microbiota to control or treat HBV infection.